Open AccessRemission of Merkel cell tumor after somatostatin analog treatment
Author(s) -
Mahmoud Fakiha,
Paule Letertre,
JeanPhilippe Vuillez,
J. Lebeau
Publication year - 2010
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.73352
Subject(s) - lanreotide , merkel cell carcinoma , somatostatin , medicine , merkel cell , oncology , somatostatin analogue , cancer research , octreotide , carcinoma , hormone , growth hormone , acromegaly
We recently treated one patient presenting with a disseminated non-operable Merkel cell carcinoma (MCC) by lanreotide (somatostatin analog), with a complete remission of the disease and a follow up of 17 months. We present in this paper a case report with a review of the utilization of somatostatin analogues in the treatment of MCC.